Metabolomics

Biography

Biography: Dongliang Ge

Abstract

The biopharmaceutical industry has quickly entered an era when fast evolving mutil-disciplilinary omics technologies, historical precision medicine initiatives, and disruptive bioinformatics techniques synergistically start to provide pivotal and strategic support for new drug development. Unprecedented amount of data is being generated to help discover and develop new generations of medications. Using examples, this talks covers several of the most important bioinformatic considerations in this strategy. How do we efficiently manage the massive amount of data at different levels of precision to ensure a seamless data flow? How do we annotate and present these data to make it more comprehensible and deliverable? How do we design and execute the new clinical trials more efficiently and improve the success rate? Where are we and where are we going in this new precision medicine era?